FOX
Vectura GmbH
Trademark Registered: 2016-07-05
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79170284 |
| Registration Number | 4990858 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Molly B. Markley |
| Attorney Docket Number | AJO2-294-MAD |
| Law Office Assigned | M60 |
| Employee Name | FLETCHER, TRACY L |
Timeline
| 2015-04-27 | Application Filed |
| 2016-04-19 | Published for Opposition |
| 2016-07-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-07-05 | Status: Live/Registered |
| 2016-07-05 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Vectura GmbH |
| Entity Statement | GmbH |
| Address | Robert-Koch-Allee 29 82131 Gauting DE |
| Legal Entity Type | |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of, and protection against, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the prevention and treatment of and protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and medicated skin and tissue repair preparations; medical and veterinary pharmaceutical preparations for use in inhalers and nebulizers for the prevention and treatment of lung disease, lung infections and respiratory ailments; medical and veterinary pharmaceutical preparations and medicaments for use in inhalers and nebulizers for treating erectile dysfunction, premature ejaculation, female sexual dysfunction, chronic obstructive pulmonary disease, asthma, cystic fibrosis, migraine, and Parkinson's disease; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems; none of the aforementioned goods including medicated confectionary |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2015-08-06 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-08-08 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-08-08 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2015-08-12 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2015-08-15 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2015-08-16 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2015-08-17 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-08-17 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2015-09-04 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-02-17 | 10 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2016-02-23 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-03-01 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-03-01 | 13 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2016-03-04 | 14 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2016-03-04 | 15 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-03-04 | 16 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2016-03-04 | 17 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-03-04 | 18 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-03-14 | 19 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-03-30 | 20 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-04-19 | 21 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-04-19 | 22 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-07-05 | 23 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-10-05 | 24 FICR P: |
| FINAL DISPOSITION PROCESSED | 2016-10-21 | 25 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-10-21 | 26 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-11-11 | 27 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2017-02-23 | 28 ADCH M: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2021-07-05 | 29 REM3 E:E-Mail |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-10-08 | 30 NREP P: |
| CANCELLED SECTION 71 | 2023-01-20 | 31 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2023-09-20 | 32 INTR P: |
| INVALIDATION PROCESSED | 2023-09-27 | 33 INPC P: |
| TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2023-09-27 | 34 INTS P: |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2023-10-16 | 35 INNT P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 